<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00006295</url>
  </required_header>
  <id_info>
    <org_study_id>912</org_study_id>
    <secondary_id>R01HL061369</secondary_id>
    <nct_id>NCT00006295</nct_id>
  </id_info>
  <brief_title>Molecular &amp; Clinical Evaluation of Low HDL Syndromes</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Maryland</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Heart, Lung, and Blood Institute (NHLBI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Maryland</source>
  <brief_summary>
    <textblock>
      To study the genetic cause of low HDL-C, a risk factor for premature atherosclerotic vascular
      disease in patients with normal total cholesterol. The focus is primarily on the
      identification of a single mutation, as has been demonstrated in one family.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      BACKGROUND:

      Low levels of high density lipoprotein cholesterol (HDL-C) have been found to be associated
      with an increased risk for coronary artery disease (CAD). However, the genetic basis for this
      association is not well understood and the clinical implications of this association have not
      been extensively addressed. The study, in seeking to elucidate the genetic basis for low
      HDL-C and examine the clinical implications of low HDL-C, focuses upon an important research
      topic.

      DESIGN NARRATIVE:

      Specific aims of the study include: 1) Collection and characterization of plasma and DNA from
      probands with very low HDL-C. Linkage analysis will be performed using highly polymorphic
      markers within or near HDL-C candidate genes. The hypothesis to be tested is that polymorphic
      microsatellites segregate with the low HDL-C phenotype.

      2) Further genetic characterization of families evidence of linkage to specific HDL-C
      candidate genes identified in Specific Aim 1. The hypothesis to be tested is that structural
      variants in HDL-C candidates are responsible for low HDL-C.

      3) Evaluate the physiologic significance of novel genomic variants identified in Specific Aim
      2. The hypothesis to be tested is that structural variants will affect expression of the gene
      product.

      4) Examine early atherosclerosis in low HDL-C syndromes. The hypothesis to be tested is that
      increased carotid intima-medial thickness is prevalent with isolated low HDL-C.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2000</start_date>
  <completion_date type="Actual">July 2006</completion_date>
  <primary_completion_date type="Actual">July 2006</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Family-Based</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Gene discovery</measure>
    <time_frame>20 years</time_frame>
  </primary_outcome>
  <number_of_groups>12</number_of_groups>
  <enrollment type="Anticipated">370</enrollment>
  <condition>Cardiovascular Diseases</condition>
  <condition>Heart Diseases</condition>
  <condition>Atherosclerosis</condition>
  <arm_group>
    <arm_group_label>Pedigree 1</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Pedigree 2</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Pedigree 3</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Pedigree 4</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Pedigree 5</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Pedigree 6</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Pedigree 7</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Pedigree 8</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Pedigree 9</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Pedigree 10</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Pedigree 11</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Pedigree 12</arm_group_label>
  </arm_group>
  <eligibility>
    <criteria>
      <textblock>
        No eligibility criteria
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <reference>
    <citation>Hong SH, Riley W, Rhyne J, Friel G, Miller M. Lack of association between increased carotid intima-media thickening and decreased HDL-cholesterol in a family with a novel ABCA1 variant, G2265T. Clin Chem. 2002 Nov;48(11):2066-70.</citation>
    <PMID>12407001</PMID>
  </reference>
  <reference>
    <citation>Hong SH, Rhyne J, Zeller K, Miller M. ABCA1(Alabama): a novel variant associated with HDL deficiency and premature coronary artery disease. Atherosclerosis. 2002 Oct;164(2):245-50. Review.</citation>
    <PMID>12204794</PMID>
  </reference>
  <reference>
    <citation>Ho Hong S, Rhyne J, Zeller K, Miller M. Novel ABCA1 compound variant associated with HDL cholesterol deficiency. Biochim Biophys Acta. 2002 May 21;1587(1):60-4.</citation>
    <PMID>12009425</PMID>
  </reference>
  <reference>
    <citation>Miller M, Zhan M, Georgopoulos A. Effect of desirable fasting triglycerides on the postprandial response to dietary fat. J Investig Med. 2003 Feb;51(1):50-5. doi: 10.2310/6650.2003.33544.</citation>
    <PMID>12580321</PMID>
  </reference>
  <reference>
    <citation>Friend M, Vucenik I, Miller M. Research pointers: Platelet responsiveness to aspirin in patients with hyperlipidaemia. BMJ. 2003 Jan 11;326(7380):82-3.</citation>
    <PMID>12521973</PMID>
  </reference>
  <reference>
    <citation>Miller M. Niacin as a component of combination therapy for dyslipidemia. Mayo Clin Proc. 2003 Jun;78(6):735-42. Review.</citation>
    <PMID>12934785</PMID>
  </reference>
  <reference>
    <citation>Miller M, Zhan M. Genetic determinants of low high-density lipoprotein cholesterol. Curr Opin Cardiol. 2004 Jul;19(4):380-4. Review.</citation>
    <PMID>15218400</PMID>
  </reference>
  <reference>
    <citation>Hong SH, Rhyne J, Miller M. Novel polypyrimidine variation (IVS46: del T -39...-46) in ABCA1 causes exon skipping and contributes to HDL cholesterol deficiency in a family with premature coronary disease. Circ Res. 2003 Nov 14;93(10):1006-12. Epub 2003 Oct 23.</citation>
    <PMID>14576201</PMID>
  </reference>
  <reference>
    <citation>Ahmad I, Zhan M, Miller M. High prevalence of C-reactive protein elevation with normal triglycerides (100-149 mg/dL): are triglyceride levels below 100 mg/dL more optimal in coronary heart disease risk assessment? Am J Med Sci. 2005 Apr;329(4):173-7.</citation>
    <PMID>15832099</PMID>
  </reference>
  <reference>
    <citation>Miller M, Zhan M, Havas S. High attributable risk of elevated C-reactive protein level to conventional coronary heart disease risk factors: the Third National Health and Nutrition Examination Survey. Arch Intern Med. 2005 Oct 10;165(18):2063-8.</citation>
    <PMID>16216995</PMID>
  </reference>
  <verification_date>January 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 25, 2000</study_first_submitted>
  <study_first_submitted_qc>September 25, 2000</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 26, 2000</study_first_posted>
  <last_update_submitted>August 19, 2016</last_update_submitted>
  <last_update_submitted_qc>August 19, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 23, 2016</last_update_posted>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cardiovascular Diseases</mesh_term>
    <mesh_term>Heart Diseases</mesh_term>
    <mesh_term>Atherosclerosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

